UB Paderborn / Katalog / Suche / in CDI

Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom

Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5952-5954

2011

Link zum Volltext

Verfügbarkeit prüfen

CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens

Journal of medical microbiology, 2017-11, Vol.66 (11), p.1554-1561

2017

Link zum Volltext

Verfügbarkeit prüfen

Atypical microbial keratitis

The ocular surface, 2023-04, Vol.28, p.424-439

2023

Link zum Volltext

Verfügbarkeit prüfen

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

Antimicrobial agents and chemotherapy, 2015-08, Vol.59 (8), p.4544-4550

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vitro and In Vivo Activities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial agents and chemotherapy, 2014-06, Vol.58 (6), p.3541-3546

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae

Journal of clinical microbiology, 2016-02, Vol.54 (2), p.471-473

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii

Journal of antimicrobial chemotherapy, 2019-04, Vol.74 (4), p.961-969

2019

Link zum Volltext

Verfügbarkeit prüfen

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections

Journal of antimicrobial chemotherapy, 2020-01, Vol.75 (1), p.135-139

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3080-3085

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus

Journal of natural products (Washington, D.C.), 2015-08, Vol.78 (8), p.2145-2148

2015

Link zum Volltext

Verfügbarkeit prüfen

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections—authors’ response

Journal of antimicrobial chemotherapy, 2020-09, Vol.75 (9), p.2713-2713

2020

Link zum Volltext

Verfügbarkeit prüfen

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis

Scientific reports, 2022-12, Vol.12 (1), p.21429-21429, Article 21429

2022

Link zum Volltext

Verfügbarkeit prüfen

A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam

Journal of antimicrobial chemotherapy, 2019-11, Vol.74 (11), p.3392-3394

2019

Link zum Volltext

Verfügbarkeit prüfen

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability

Journal of antimicrobial chemotherapy, 2015-02, Vol.70 (2), p.463-469

2015

Link zum Volltext

Verfügbarkeit prüfen

Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone

Microbial drug resistance (Larchmont, N.Y.), 2016-07, Vol.22 (5), p.379

2016

Link zum Volltext

Verfügbarkeit prüfen

Carbapenemase-producing organism (CPO) colonisation at a district general hospital: universal screening may help reduce transmission

Infection prevention in practice, 2021-09, Vol.3 (3), p.100164-100164, Article 100164

2021

Link zum Volltext

Verfügbarkeit prüfen

Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam

Journal of global antimicrobial resistance., 2017-06, Vol.9, p.96-99

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo activity of ML302F: a thioenolate inhibitor of VIM-subfamily metallo β-lactamases

MedChemComm, 2016-01, Vol.7 (1), p.19-193

2016

Link zum Volltext

Verfügbarkeit prüfen

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting

Journal of antimicrobial chemotherapy, 2021-08, Vol.76 (9), p.2252-2259

2021

Link zum Volltext

Verfügbarkeit prüfen

715. Evaluation of Four Chromogenic Selective Media for the Isolation of Candida auris

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S457-S457

2021

Link zum Volltext

Verfügbarkeit prüfen

In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection

International journal of antimicrobial agents, 2013-03, Vol.41 (3), p.285-287

2013

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens

International journal of antimicrobial agents, 2013-10, Vol.42 (4), p.343-346

2013

Link zum Volltext

Verfügbarkeit prüfen

Unorthodox antimicrobial combination therapies for the treatment of multi-drug resistant gram-negative infections

Phee, Lynette

2018

Link zum Volltext
ProQuest

Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase

Journal of clinical pathology, 2013-04, Vol.66 (4), p.348-350

2013

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital outbreak

Infection prevention in practice, 2020-09, Vol.2 (3), p.100021-100021, Article 100021

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom

CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens

Atypical microbial keratitis

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

In Vitro and In Vivo Activities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae

Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections

In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections—authors’ response

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis

A novel plasmid-mediated polymyxin resistance determinant (mcr-1.8) in Escherichia coli recovered from broiler chickens in Brunei Darussalam

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability

Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone

Carbapenemase-producing organism (CPO) colonisation at a district general hospital: universal screening may help reduce transmission

Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam

In vitro and in vivo activity of ML302F: a thioenolate inhibitor of VIM-subfamily metallo β-lactamases

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting

715. Evaluation of Four Chromogenic Selective Media for the Isolation of Candida auris

In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens

Unorthodox antimicrobial combination therapies for the treatment of multi-drug resistant gram-negative infections

Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase

Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital outbreak

Suchergebnisse filtern